Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 27.07.2021 at 12:00 PM CEST
Settings

Settings

Goto Application

1. WO2020139999 - PANCREATIC CANCER TREATMENT

Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

[ EN ]

CLAIMS

1. A method for treating pancreatic cancer comprising administering an effective amount of a composition comprising palmatine or palmatine derivative to a patient that has pancreatic cancer.

2. The method of claim 1, wherein the composition further comprises a pharmaceutically acceptable carrier.

3. The method of claim 1, further comprising administering an effective amount of chemotherapy agents.

4. The method of claim 3, wherein the chemotherapy agent is gemcitabine, oxaliplatin, irinotecan, leucovorin, 5-FU (FOLFIRINOX) or combination thereof.

5. The method of claim 4, wherein the chemotherapy agent is gemcitabine.

6. The method of claim 1 , wherein the chemotherapy agent is administered simultaneously or about 1, 2, 3, 4, 5, 6, 7, 8, ,9 10, seconds, minutes, hours or days, before or after administration of palmatine.

7. The method of claim 1, wherein pancreatic cancer is advanced pancreatic ductal adenocarcinoma.

8. An anti-pancreatic cancer composition comprising palmatine and a chemotherapy agent.

9. The composition of claim 1, wherein the chemotherapy agent is gemcitabine, oxaliplatin, irinotecan, leucovorin, 5-FU (FOLFIRINOX) or combination thereof.

10. The composition of claim 9, wherein the chemotherapy agent is gemcitabine.